-- 
Partner, Teva, Bioline Rx, Koor, Magal: Israeli Equity Preview

-- B y   S h o s h a n n a   S o l o m o n
-- 
2011-09-14T06:36:11Z

-- http://www.bloomberg.com/news/2011-09-14/partner-teva-bioline-rx-koor-magal-israeli-equity-preview.html
The following stocks may rise or
fall in Israeli markets. Stock symbols are in parentheses after
the company names and prices are from the last close unless
otherwise stated.  The TA-25 Index gained 2 percent to 1,019.81 in  Tel Aviv .  Bioline Rx Ltd. (BLRX)  : Shares of the Israeli
biopharmaceutical company jumped 38 percent in  New York  after a
clinical trial showed its drug for neuropathic pain is safe.
Bioline rose 0.6 percent to 1.134 shekels in Tel Aviv.  Koor Industries Ltd. (KOR)  :  Discount Investment Corp. (DISI) 
 offered to buy an additional 3.3 million shares, or 7
percent, of the holding company at 35 shekels per share. Koor
climbed 9.2 percent to 30.21 shekels. Discount rose 0.9 percent
to 26.33 shekels.       Magal Security Systems Ltd. (MAGS)  : The manufacturer of
computerized security systems will delist from the Tel Aviv
Stock Exchange on Dec. 1. Magal declined 2.1 percent to 8.623
shekels.  Partner Communications Co. (PTNR IT): Israel’s second-
largest mobile-phone operator appointed Haim Romano chief
executive officer, effective Oct. 2, after Yacov Gelbard stepped
down. Partner was unchanged at 35.3 shekels.  Teva Pharmaceutical Industries Ltd. (TEVA)  : The world’s
largest maker of generic drugs, said it will invest $19 million
in the CureTech Ltd. unit of  Clal Biotechnology Industries Ltd. (CBI) 
 Teva gained 0.3 percent to 139.60 shekels. Clal
increased 2.2 percent to 14.83 shekels.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  